Drugs / Black cumin
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06404606 | Jun → Dec 2024 | osteoarthritis | Pakistan Society for Rehabilitation of Differently Abled Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Black cumin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06404606 ↗ |
| Known as | Nigella sativa | “For many centuries, seeds of Nigella sativa (black cumin), a dicotyledon of the Ranunculaceae family, have been used as a seasoning spice and food additive in the Middle East...” PMID 26366755 ↗ Sep 2015 |
| Modality | Traditional medicine (herbal / TCM) | “Traditionally, the plant is used for asthma, hypertension, diabetes, inflammation, cough, bronchitis, headache, eczema, fever, dizziness, and gastrointestinal disturbances.” PMID 26366755 ↗ Sep 2015 |